Managing drug safety without an organized timeline is like navigating a maze blindfolded. Critical safety checks might overlap or be missed, and deadlines can catch you off guard.
Here’s what typically goes wrong without a timeline view tailored for drug safety:
- Complex safety assessments become tangled — tracking adverse event reports and follow-ups grows confusing.
- Regulatory submissions risk delays — no clear visibility into due dates and dependencies.
- Cross-team communication falters — safety data and updates scattered across emails and spreadsheets.
- Monitoring plans lose clarity — unclear sequencing leads to duplicated or skipped safety evaluations.
- Audit readiness suffers — documentation and timelines aren’t easily accessible or updated.
- Resource allocation misfires — coordinating pharmacovigilance tasks without a timeline causes bottlenecks.
- Progress tracking is difficult — hard to see which safety activities are complete or pending.
- Risk of non-compliance grows — missed timelines can lead to regulatory penalties.